This article is part of the supplement: The evolution of anti-TNF therapy in rheumatic disease: experience, insights and advances

Highly Accessed Review

Advances in rheumatology: new targeted therapeutics

Paul P Tak* and Joachim R Kalden

  • * Corresponding author: Paul P Tak

Arthritis Research & Therapy 2011, 13(Suppl 1):S5 doi:10.1186/1478-6354-13-S1-S5

Accesses  

  • Last 30 days: 279 accesses
  • Last 365 days: 3844 accesses
  • All time: 10668 accesses

Cited by

BioMed Central: 3 citations